TIMBER PHARMACEUTICALS INC (TMBR) Stock Income Statement
NYSEARCA:TMBR - NYSE Arca - US8870802084 - Common Stock - Currency: USD
| TTM (2022-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-1-31) | 2019 (2019-1-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 80.00K | 890.00K | 0.00 | 60.00K | |||
| Cost Of Goods | N/A | N/A | N/A | 0.00 | 80.00K | |||
| Gross Profit | N/A | N/A | N/A | 0.00 | -30.00K | |||
| Operating Expenses | 14.54M | 19.32M | 11.54M | 9.69M | 16.48M | |||
| Research and Development | 8.73M | 13.30M | 6.15M | 4.69M | 9.08M | |||
| Selling, General, and Administrative Expenses | 5.81M | 6.02M | 5.39M | 5.00M | 7.40M | |||
| Operating Income | -14.54M | -19.24M | -10.65M | -9.69M | -16.51M | |||
| Interest Income/Expense | -230.08K | -250.00K | -20.00K | 290.00K | 30.00K | |||
| Other Income/Expense | 0.00 | 80.00K | N/A | -290.00K | -780.00K | |||
| Non Recurring Items | -160.00K | 40.00K | 0.00 | -1.50M | N/A | |||
| Income Before Taxes | -14.93M | -19.37M | -10.67M | -9.69M | -17.26M | |||
| Income Tax | 10.00K | 10.00K | -30.00K | 0.00 | 0.00 | |||
| Net Income | -14.93M | -19.38M | -10.77M | -9.69M | -17.26M | |||
| EBITDA | N/A | N/A | N/A | -9.63M | -16.45M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.88 | -9.19 | -13.31 | -484.49 | -1.73K | |||
| Non GAAP EPS | N/A | N/A | N/A | -9.91 | -16.68 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | -50.00% | |||
| Profit Margin | N/A | -24225.00% | -1210.11% | N/A | -28766.67% | |||
| Operating Profit Margin | N/A | -24050.00% | -1196.63% | N/A | -27516.67% | |||
All data in USD